Clinical Importance of estrogen reactivity in Hormone Receptor Positive HER2-Negative Breast Cancer

被引：0
|
作者：
Takeshita, Takashi [1 ]
Iwase, Hirotaka [1 ]
Takabe, Kazuaki [2 ]
机构：
[1] Kumamoto City Hosp, Kumamoto, Japan
[2] Roswell Pk Comprehens Canc Ctr, New York, NY USA
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1185
引用
收藏
页码：597 / 597
页数：1
相关论文
共 50 条
  • [41] PROGESTERON RECEPTOR STATUS IN DETERMINING THE PROGNOSIS OF ESTROGEN RECEPTOR POSITIVE/HER2-NEGATIVE BREAST CARCINOMA
    Arslan, U. Yalcintas
    Bal, O.
    Ozatli, T.
    Helvaci, K.
    Esbah, O.
    Budakoglu, B.
    Uyeturk, U.
    Sonmez, O. U.
    Turker, I.
    Oksuzoglu, O. B.
    ANNALS OF ONCOLOGY, 2012, 23 : 105 - 105
  • [42] Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer
    Fujii, T.
    Kogawa, T.
    Dong, W.
    Sahin, A. A.
    Moulder, S.
    Litton, J. K.
    Tripathy, D.
    Iwamoto, T.
    Hunt, K. K.
    Pusztai, L.
    Lim, B.
    Shen, Y.
    Ueno, N. T.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2420 - 2428
  • [43] New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer
    Martinello, Rossella
    Genta, Sofia
    Galizia, Danilo
    Geuna, Elena
    Milani, Andrea
    Zucchini, Giorgia
    Valabrega, Giorgio
    Montemurro, Filippo
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (16) : 2179 - 2189
  • [44] Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer
    de Boer, Richard
    Hui, Rina
    Lim, Elgene
    Yeo, Belinda
    Zdenkowski, Nicholas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 3 - 14
  • [45] Characterization of Weakly Hormone Receptor (HR)-Positive, HER2-Negative Breast Cancer and Current Treatment Strategies
    Poterala, Johanna E.
    Havighurst, Thomas
    Wisinski, Kari Braun
    CLINICAL BREAST CANCER, 2022, 22 (06) : 611 - 618
  • [46] Current Management and Future Perspectives of Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
    Gilchrist, Jenny
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [47] Treatment differences by race and age in metastatic hormone receptor-positive/HER2-negative breast cancer
    Abdou, Yara
    Ivory, Joannie
    Deal, Allison
    Wardell, Ally
    Wheless, Amy
    Dees, Claire
    Carey, Lisa
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases
    Minetta C. Liu
    Javier Cortés
    Joyce O’Shaughnessy
    Cancer and Metastasis Reviews, 2016, 35 : 323 - 332
  • [49] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Linnea T. Olsson
    Alina M. Hamilton
    Sarah C. Van Alsten
    Jennifer L. Lund
    Til Stürmer
    Hazel B. Nichols
    Katherine E. Reeder-Hayes
    Melissa A. Troester
    Breast Cancer Research and Treatment, 2024, 204 : 107 - 116
  • [50] Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
    Olsson, Linnea T.
    Hamilton, Alina M.
    Van Alsten, Sarah C.
    Lund, Jennifer L.
    Sturmer, Til
    Nichols, Hazel B.
    Reeder-Hayes, Katherine E.
    Troester, Melissa A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 107 - 116
12345